AboutSign In

TauRx Pharmaceuticals

Organization

Pharmaceutical company developing hydromethylthionine mesylate, an oral tau aggregation inhibitor for Alzheimer's

1 story

01
health1h ago

Experimental Drug Shows First-Ever Reduction in Tau Pathology and Cognitive Benefit in Early Alzheimer's Trial

10 min read